Table 2.
Assessment Time Points | Meeting Clinical Significance N (%) | Symptom Severity M (SD) |
---|---|---|
Baseline (N=99) | 16 (16.2%) | 28.52 (12.11) |
3-Month Post-Hospitalization (N=79) | 14 (17.7%) | 30.41 (12.11) |
6-Month Post-Hospitalization (N=79) | 17 (21.5%) | 30.03 (14.59) |
Note. Clinical significance for PTSD as determined on the Post-Traumatic Checklist-Specific Stressor (PCL-S) by symptoms rated “moderately” or above for at least: one B cluster item (questions 1-5); three C cluster items (questions 6-12); and two D cluster items (questions 13-17).